Placebo-Controlled Trials, Ethics of

International Encyclopedia of the Social & Behavioral Sciences: Second Edition

Volumn , Issue , 2015, Pages 164-173

  van der Graaf, Rieke ^a   Rid, Annette ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical equipoise; Clinical research ethics; Clinical trial design; Clinical trials; Human subjects research; Investigator obligations; LMICs (low and middle income countries); Placebo; Placebo controlled trials; Randomized clinical trials; Risks; Therapeutic obligations

Indexed keywords

EID: 85018297233     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-097086-8.11011-6     Document Type: Chapter

References (61)

1. Angell M. The ethics of clinical research in the Third World. New England Journal of Medicine 1997, 337(12):847-849.
2. Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. British Medical Journal 2000, 321(7256):255-256.
3. Beauchamp T.L., Childress J.F. Principles of Biomedical Ethics 2013, Oxford University Press, Oxford. seventh ed.
4. Global Health and Global Health Ethics 2011, Cambridge University Press, Cambridge. S.R. Benatar, G. Brock (Eds.).
5. Brazil, Conselho Nacional de Saúde, RESOLUÇÕCNS No 404 (2008). http://conselho.saude.gov.br/web_comissoes/conep/aquivos/resolucoes/resolucoes.htm.
6. Brim R.L., Miller F.G. The potential benefit of the placebo effect in sham-controlled trials: implications for risk"benefit assessments and informed consent. Journal of Medical Ethics 2013, 39(11):703-707.
7. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans 2010, Interagency Advisory Panel on Research Ethics, Government of Canada, Ontario, Canada.
8. Cartwright N. A philosopher's view of the long road from RCTs to effectiveness. Lancet 2011, 377(9775):1400-1401.
9. Colloca L., Finniss D. Nocebo effects, patient"clinician communication, and therapeutic outcomes. Journal of the American Medical Association 2012, 307(6):567-568.
10. Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine 2000, 243(25):1887-1892.
11. Council for International Organizations of Medical Sciences (CIOMS), Ethical Guidelines for Biomedical Research Involving Human Subjects 2002, http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm.
12. Council of Europe, Additional Protocol to the Convention on Human Rights and Biomedicine, Concerning Biomedical Research 2005, http://conventions.coe.int/Treaty/en/Treaties/Html/195.htm.
13. Food and Drug Administration. 21 Code of Federal Regulations Part 312. Human Subject Protection; Foreign Clinical Studies Not Conducted under an Investigational New Drug Application 2008, Department of Health and Human Services. http://www.fda.gov/ohrms/dockets/98fr/E8-9200.htm.
14. Food and Drug Administration 21 Code of Federal Regulations 2013, Department of Health and Human Services, Chapter 1. Subchapter D. Part 314. Subpart D. Sec 314.126 Adequate and well-controlled studies. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=314.126.
15. Ellenberg S.S., Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Annals of Internal Medicine 2000, 133(6):464-470.
16. Emanuel E.J. Global justice and the "standard of care" debates. Global Justice and Bioethics 2012, 181-212. Oxford University Press, Oxford. J. Millum, E.J. Emanuel (Eds.).
17. Emanuel E.J., Miller F.G. The ethics of placebo-controlled trials " a middle ground. New England Journal of Medicine 2001, 345(12):915-919.
18. Emanuel E.J., Wendler D., Grady C. What makes clinical research ethical?. JAMA 2000, 283(20):2701-2711.
19. Freedman B. Equipoise and the ethics of clinical research. New England Journal of Medicine 1987, 317(3):141-145.
20. Freedman B., Weijer C., Glass K.C. Placebo orthodoxy in clinical research. I: Empirical and methodological myths. Journal of Law, Medicine & Ethics 1996, 24(3):243-251.
21. Freedman B., Glass K.C., Weijer C. Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths. Journal of Law, Medicine & Ethics 1996, 24(3):252-259.
22. Fried C. Medical Experimentation: Personal Integrity and Social Policy 1974, North-Holland Publishing Company, Amsterdam.
23. Friedman L.M., Furberg C.D., DeMets D.L. Fundamentals of Clinical Trials 2010, New York. fourth ed.
24. van der Graaf R., van Delden J.J.M. What is the best standard for the standard of care?. American Journal of Bioethics 2009, 9(3):35-43.
25. van der Graaf R., van Delden J.J.M. Equipoise should be amended, not abandoned. Clinical Trials 2012, 9(5):628-629.
26. Hawkins J.S. Exploitation and placebo controls. Exploitation and Developing Countries. The Ethics of Clinical Research 2008, 246-285. Princeton University Press, Princeton. J.S. Hawkins, E.J. Emanuel (Eds.).
27. Exploitation and Developing Countries. The Ethics of Clinical Research 2008, Princeton University Press, Princeton. J.S. Hawkins, E.J. Emanuel (Eds.).
28. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), ICH Harmonised Tripartite Guideline: Choice of Control Group and Related Issues in Clinical Trials, 2000. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E10/Step4/E10_Guideline.pdf.
29. Kam-Hansen S., Jakubowski M., Kelley J.M., Kirsch I., Hoaglin D.C., Kaptchuk T.J., Burstein R. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Science Translational Medicine 2014, 6(218):218ra5.
30. Kaptchuk T.J. Powerful placebo: the dark side of the randomized controlled trial. Lancet 1998, 351:1722-1725.
31. Kukla R. Resituating the principle of equipoise: justice and access to care in non-ideal conditions. Kennedy Institute of Ethics Journal 2007, 17(3):171-202. http://www.ncbi.nlm.nih.gov/pubmed/?term=kukla+equipoise.
32. Lie R.K., Emanuel E., Grady C., Wendler D. The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. Journal of Medical Ethics 2004, 30(2):190-193.
33. London A.J., Kadane J.B. Placebos that harm: sham surgery controls in clinical trials. Statistical Methods in Medical Research October 2002, 11(5):413-427.
34. London A.J. Equipoise and international human-subjects research. Bioethics 2001, 15(4):312-332.
35. London A.J. The ambiguity and the exigency: clarifying "standard of care" arguments in international research. Journal of Medicine and Philosophy 2000, 25(4):379-397.
36. Lurie P., Wolfe S.M. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. New England Journal of Medicine 1997, 337(12):853-856.
37. Macklin R. Double Standards in Medical Research in Developing Countries 2004, Cambridge University Press, Cambridge.
38. Marquis D. Leaving therapy to chance. Hastings Center Report 1983, 13(4):40-47.
39. Miller F.G., Joffe S. Equipoise and the dilemma of randomized clinical trials. New England Journal of Medicine 2011, 364(5):476-480.
40. Miller F.G. The ethics of placebo-controlled trials. The Oxford Textbook of Clinical Research 2008, 261-272. OUP, Oxford. Emanuel (Ed.).
41. Miller F.G., Brody H. Clinical equipoise and the incoherence of research ethics. Journal of Medicine and Philosophy 2007, 32(2):151-165.
42. Miller F.G., Brody H. Therapeutic misconception in the ethics of clinical trials. A critique of clinical equipoise. Hastings Center Report 2003, 33(3):19-28.
43. Miller F.G. Sham surgery: an ethical analysis. American Journal of Bioethics 2003, 3(4):41-48.
44. Miller F.G., Brody H. What makes placebo-controlled trials unethical?. American Journal of Bioethics 2002 Spring, 2(2):3-9.
45. Millum J., Grady C. The ethics of placebo-controlled trials: methodological justifications. Contemporary Clinical Trials 2013, 36(2):510-514.
46. Millum J., Emanuel E.J. Global Justice and Bioethics 2012, Oxford University Press, Oxford.
47. The Ethics of Research Related to Health Care in Developing Countries 2002, Nuffield Council on Bioethics, Nuffield Council on Bioethics, London.
48. Petryna A. When Experiments Travel 2009, Princeton University Press, Princeton.
49. Pogge T. World Poverty and Human Rights 2002, Polity Press, Cambridge.
50. Resnik D.B. The ethics of HIV research in developing nations. Bioethics 1998, 12(4):286-306.
51. Rid A., Wendler D. A framework for risk"benefit evaluations in biomedical research. Kennedy Institute of Ethics Journal 2011, 21(2):141-179.
52. Rothman K.J., Michels K.B. The continuing unethical use of placebo controls. New England Journal of Medicine 1994, 331:394-398.
53. Sacks H., Chalmers T.C., Smith H. Randomized versus historical controls for clinical trials. American Journal of Medicine 1982, 72:233-240.
54. Sackett D.I., Rosenberg W.M.C., Gray J.A.M., Haynes R.B., Richardson W.S. Evidence based medicine: what it is and what it isn't. British Medical Journal 1996, 312:71-72.
55. Ethics in Health Research: Principles, Structures, and Processes 2004, South African Department of Health, Research Ethics Guidelines. http://www.nhrec.org.za/wp-content/uploads/2011/ethics.pdf.
56. Stone M., Laughren T., Jones M.L., Levenson M., Holland P.C., Hughes A., et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. British Medical Journal 2009, 339:b2880.
57. Temple R., Ellenberg S.S. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Annals of Internal Medicine 2000, 133(6):455-463.
58. National Guidelines for Research Involving Humans as Research Participants 2007, Uganda National Council for Science and Technology (UNCST). http://www.uncst.go.ug/.
59. Varmus H., Satcher D. Ethical complexities of conducting research in developing countries. New England Journal of Medicine 1997, 337(14):1003-1005.
60. Weijer C., Miller P.B. When are research risks reasonable in relation to anticipated benefits?. Nature Medicine 2004, 10(6):570-573.
61. Declaration of Helsinki 2013, World Medical Association (WMA), Fortaleza, Brazil. http://www.wma.net/en/30publications/10policies/b3/.